Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas
- 1 January 1996
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 97 (1) , 91-94
- https://doi.org/10.1007/bf00218840
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.1995
- Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.Genes & Development, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Published by Elsevier ,1994
- Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.1994
- A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.Molecular and Cellular Biology, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993